Darif 7.5 Mg Tablet (10 Tab)

DARIF 7.5 MG TABLET

DARIF 7.5 MG TABLET, manufactured by Alembic Pharmaceuticals Limited, is an extended-release medication used to manage symptoms of overactive bladder.

Composition

The active ingredient in DARIF 7.5 MG TABLET is Darifenacin hydrobromide, in a 7.5 mg extended-release formulation. Darifenacin is a selective M3 muscarinic receptor antagonist that works by relaxing the bladder muscles.

Uses

DARIF 7.5 MG TABLET is prescribed for the treatment of overactive bladder (OAB) symptoms in adults. These symptoms include:

• Urge urinary incontinence (urine leakage due to a strong, sudden urge to urinate)
• Urgency (a strong, immediate need to urinate)
• Frequency (urinating often) By relaxing bladder muscles, it helps to increase the bladder's capacity to hold urine and reduce uncontrollable contractions.

Dosage and Administration

The typical starting dose of DARIF 7.5 MG TABLET is 7.5 mg taken orally once daily. Based on individual patient response and tolerability, the dose may be increased to 15 mg once daily, as early as two weeks after initiating therapy.

The tablet should be swallowed whole with water and must not be crushed, chewed, or divided. It can be taken with or without food. Do not discontinue the medication without consulting a doctor, as this may worsen symptoms.

Special dosage considerations apply for certain patients:

• For patients with moderate hepatic impairment (Child-Pugh B), the daily dose should not exceed 7.5 mg.
• Use is not recommended for patients with severe hepatic impairment (Child-Pugh C).
• When co-administered with potent CYP3A4 inhibitors (e.g., ketoconazole, ritonavir), the daily dose of Darifenacin should not exceed 7.5 mg.

Side Effects

Common Side Effects:

• Dry mouth
• Constipation
• Headache
• Dizziness
• Nausea or indigestion
• Blurred vision or dry eyes
• Stomach pain
• Nasal dryness

Serious Side Effects (Seek immediate medical attention if experienced):

• Angioedema (swelling of the face, lips, tongue, or throat, which can cause difficulty breathing)
• Severe stomach pain or constipation
• Urinary retention (little or no urination, inability to empty bladder)
• Confusion or hallucinations
• Signs of heat prostration or heat stroke (feeling very thirsty or hot, heavy sweating, hot and dry skin, inability to urinate)

Precautions

• Contraindications: DARIF 7.5 MG TABLET is contraindicated in patients with urinary retention, gastric retention, uncontrolled narrow-angle glaucoma, or known hypersensitivity to darifenacin.
• Medical Conditions: Exercise caution in patients with clinically significant bladder outflow obstruction, gastrointestinal obstructive disorders (e.g., severe constipation, paralytic ileus), controlled narrow-angle glaucoma, decreased gastrointestinal motility, hiatal hernia, reflux esophagitis, ulcerative colitis, myasthenia gravis, or liver impairment.
• Drug Interactions: Darifenacin can interact with other medications. Severe interactions can occur with eliglustat, thioridazine, tolvaptan, and tucatinib. Concomitant use with other anticholinergic medications (e.g., some antihistamines or other overactive bladder treatments) may increase the risk of side effects like dry mouth and dizziness. Inform your doctor about all medications you are currently taking.
• Activities: This medicine may cause blurred vision, dizziness, or drowsiness. Avoid driving or operating machinery until you know how it affects you.
• Heat Prostration: Darifenacin can reduce sweating, increasing the risk of heat prostration or heat stroke, especially during hot weather or strenuous exercise. Take extra care to avoid overheating.
• Pregnancy and Breastfeeding: Inform your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding.

Storage

Store DARIF 7.5 MG TABLET in a closed container at room temperature, ideally between 20°C to 25°C (68°F to 77°F). Excursions are permitted between 15°C to 30°C (59°F to 86°F). Keep it in a cool, dry place and protect it from light. Keep this and all medicines out of the reach of children.

What is DARIF 7.5 MG TABLET used for?

DARIF 7.5 MG TABLET is primarily used to treat the symptoms of overactive bladder (OAB). This includes conditions such as a sudden, strong urge to urinate, frequent urination, and urge urinary incontinence (inability to control urine leakage).

How does DARIF 7.5 MG TABLET work?

DARIF 7.5 MG TABLET contains Darifenacin, which is a muscarinic antagonist, specifically a selective M3 muscarinic receptor antagonist. It works by blocking the action of certain chemicals (acetylcholine) that cause the bladder muscles to contract. By relaxing the bladder muscles, it helps the bladder hold more urine and reduces the frequency and urgency of urination.

What is the usual dosage for DARIF 7.5 MG TABLET?

The recommended starting dose for Darif 7.5 MG Tablet is one 7.5 mg tablet once daily. Your doctor may increase the dose to 15 mg once daily, depending on your response and tolerability, typically after two weeks. The tablet should be swallowed whole with water, with or without food, preferably at the same time each day. Do not crush, chew, or break the tablet.

What are the possible side effects of DARIF 7.5 MG TABLET?

Common side effects include dry mouth, constipation, headache, dry eyes, and nasal dryness. Other possible side effects can include abdominal pain, indigestion, nausea, blurred vision, dizziness, fatigue, and drowsiness. Rarely, severe allergic reactions like angioedema (swelling of the face, lips, tongue, or throat) can occur, requiring immediate medical attention.

Is DARIF 7.5 MG TABLET safe during pregnancy or breastfeeding?

DARIF 7.5 MG TABLET is not recommended for use during pregnancy. It should be used with caution in breastfeeding women, as the medicine may pass into breast milk and potentially harm the infant. Always consult your doctor if you are pregnant, planning to become pregnant, or breastfeeding.

Can DARIF 7.5 MG TABLET be taken with other medications?

Yes, but caution is advised. Inform your doctor about all medications you are currently taking, including over-the-counter drugs, herbal supplements, and grapefruit juice, as they can interact with Darif 7.5 MG Tablet. The dosage may need to be adjusted if taken with strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, ritonavir, clarithromycin, nefazodone), and the dose should not exceed 7.5 mg daily.

What precautions should be taken while using DARIF 7.5 MG TABLET?

You should not take this medicine if you have certain conditions like urinary retention (inability to empty the bladder), gastric retention (difficulty emptying the stomach), uncontrolled narrow-angle glaucoma, myasthenia gravis, severe ulcerative colitis, or severe liver disease. Darif 7.5 MG Tablet is not recommended for individuals under 18 years of age. Since it may cause dizziness, blurred vision, or drowsiness, avoid driving or operating heavy machinery until you know how the medication affects you. It's also advisable to avoid alcohol as it can worsen side effects and OAB symptoms. Do not stop taking the medicine without consulting your doctor, as it may worsen your symptoms.

What happens if a dose of DARIF 7.5 MG TABLET is missed?

If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one.

How should DARIF 7.5 MG TABLET be stored?

Store DARIF 7.5 MG TABLET below 30°C, in a cool and dry place, away from light and moisture. Keep it out of reach of children and pets.